Douglas J. Hughes
Director · Immunovant, Inc.
- 2024
- Apr 9, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Douglas J. Hughes files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew J. Fromkin - $7.96M in IMVT purchases and sales in the last 12 months
- Jay S. Stout - $2.34M in IMVT purchases and sales in the last 12 months
- Melanie Gloria - $1.67M in IMVT purchases and sales in the last 12 months
- Tiago Girao - $1.41M in IMVT purchases and sales in the last 12 months
- Tuyl Christopher van - $1.17M in IMVT purchases and sales in the last 12 months
- Eric Venker - $581K in IMVT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Douglas J. Hughes?
Douglas J. Hughes is a corporate insider, tracked as Director of Immunovant, Inc. (IMVT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Douglas J. Hughes last file a Form 4?
The most recent primary Form 4 on record is dated 9 April 2026, one of 3 filings going back to 2024.
Has Douglas J. Hughes been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($503K) across all tracked filings.
